Obesity and Peritoneal Surface Disease: Outcomes after Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Appendiceal and Colon Primary Tumors

BACKGROUND: It is estimated that 37 % of the U.S. population is obese. It is unknown how obesity influences the operative and survival outcomes of cytoreductive surgery (CRS)/hyperthermic intraperitoneal chemotherapy (HIPEC) procedures. METHODS: A retrospective analysis of a prospective database of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Votanopoulos, Konstantinos I., Swords, Douglas S., Swett, Katrina R., Randle, Reese W., Shen, Perry, Stewart, John H., Levine, Edward A.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3968533/
https://ncbi.nlm.nih.gov/pubmed/23800899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-3087-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars